Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: MythMan who wrote (16784)	12/9/1998 5:02:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

MM, We have heard this time in and time out again and again. Don't hold your breath. Anyone on the net who is privy to any "inside" information certainly would be smart enough not to post it on the internet. Think about it. If he or she knew something we did not there is no motivation to advertise it on a public forum. I feel that there are only 2 factors now that will allow us price appreciation and they both lead to the same thing--increased MUSE sales etc. The Street doesn't want stories on Vivus anymore. All that matters is the bottom line. That being said, in the short run it will be a domestic marketing partner and increased Viagra safety concerns that will increase MUSE scripts. EU approval and subsequent new international orders will be the other thing that will eventually help return us to profitability. Vivus has proven nothing as of yet and the track record over the past 3 fiscal quarters has been poor. They need to sell more product. The market is there. The Viagra safety concerns is now increasing demand. Wilson needs to reach his goal on the partner deal or step down and let someone else more capable get the job done.

To: MythMan who wrote (16784)	12/9/1998 5:22:00 PM
From: VLAD	Respond to of 23519

DaiS, The Astra/Zeneca merger (according to CNBC) makes them the 3rd largest pharmaceutical company in the World behind Merk and Glaxo-Welcome. Well at least it is good to know that tiny Vivus has the world's third largest drug company as part of its international marketing arm. Dave, seeing that Zeneca is an English company and the new combined company will be headquartered in England can you call the company and perhaps obtain information on their future plans to market and sell MUSE. You indeed make for a good contact since you live in England and own Vivus. I am sure that information will now be more readily available than it was from Astra since there also was a language barrier between Swedish and English. Thanks.

To: MythMan who wrote (16784)	12/9/1998 5:45:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

MythMan....Sportakus has been singing the same song for a long time ....good news soon...week after week.... Someday he will be right......